FRANKFURT (Reuters) - German healthcare group Fresenius said on Tuesday it would not be allowed to make dividend and management bonus payments for 2023 because it decided to keep state aid it received ...
Fresenius reported mediocre results and suspended the dividend this year, but management is optimistic for fiscal 2024. The company will focus on reducing debt levels in 2024 and the deconsolidation ...
Good afternoon, and thanks, everybody, for joining us today. I'd like to welcome all of you for our full year 2022 earnings call. Our full year '22 presentation is being held in a virtual format in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results